Market Overview

Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

Share:
Related AGN
20 Stocks Moving In Tuesday's Pre-Market Session
Guy Adami And Pete Najarian Share Their Thoughts On Nvidia And Allergan
Welch & Forbes Llc Buys Chubb, Check Point Software Technologies, Johnson Controls ... (GuruFocus)
Related VRX
Watch These 7 Huge Put Purchases In Thursday Trade
Benzinga's Option Alert Recap From April 26
Jones Collombin Investment Counsel Inc Buys Stantec, First Republic Bank, Amazon. ... (GuruFocus)

Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today filed an answer
in the United States District Court for the Central District of California
responding to Valeant Pharmaceuticals International, Inc. (“Valeant”) and
Pershing Square Capital Management, L.P.'s (“Pershing Square”) counterclaims
regarding Allergan's statements on the unsustainability of Valeant's
underlying business model.

The federal court case is Allergan, Inc. v. Valeant Pharmaceuticals
International, Inc., No. 14-CV-1214-DOC (ANx) (C.D. Cal.).

Posted-In: News Hedge Funds Legal Press Releases General

 

Related Articles (AGN + VRX)

View Comments and Join the Discussion!